Rule2026-03423
Inpyrfluxam; Pesticide Tolerances
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 20, 2026
Effective
February 20, 2026
Issuing agencies
Environmental Protection Agency
Abstract
This regulation establishes tolerances for residues of inpyrfluxam in or on multiple commodities which are identified and discussed later in this document. Valent U.S.A., LLC requested these tolerances under the Federal Food, Drug, and Cosmetic Act (FFDCA).
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 34 (Friday, February 20, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 34 (Friday, February 20, 2026)]
[Rules and Regulations]
[Pages 8119-8123]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-03423]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2021-0433 and EPA-HQ-OPP-0833; FRL-13125-01-OCSPP]
Inpyrfluxam; Pesticide Tolerances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes tolerances for residues of
inpyrfluxam in or on multiple commodities which are identified and
discussed later in this document. Valent U.S.A., LLC requested these
tolerances under the Federal Food, Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective February 20, 2026. Objections and
requests for hearings must be received on or before April 21, 2026 and
must be filed in accordance with the instructions provided in 40 CFR
part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action, identified by docket
identification (ID) numbers EPA-HQ-OPP-2021-0433 and EPA-HQ-OPP-2021-
0833 are available online at <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Additional
information about dockets generally, along with instructions for
visiting the docket center in person, is available at <a href="https://www.epa.gov/dockets">https://www.epa.gov/dockets</a>.
FOR FURTHER INFORMATION CONTACT: Charles Smith, Registration Division
(7505T), Office of Pesticide Programs, Environmental Protection Agency,
1200 Pennsylvania Ave. NW, Washington, DC 20460-0001; main telephone
number: (202) 566-1030; email address: <a href="/cdn-cgi/l/email-protection#16445250445879627f7573655673667738717960"><span class="__cf_email__" data-cfemail="5a081e1c0814352e33393f291a3f2a3b743d352c">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
I. Executive Summary
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them:
<bullet> Crop production (NAICS code 111).
<bullet> Animal production (NAICS code 112).
<bullet> Food manufacturing (NAICS code 311).
<bullet> Pesticide manufacturing (NAICS code 32532).
If you have any questions regarding the applicability of this
action to a particular entity, consult the person listed under FOR
FURTHER INFORMATION CONTACT.
B. What is EPA's authority for taking this action?
EPA is issuing this rulemaking under section 408 of the Federal
Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 346a. FFDCA section
408(b)(2)(A)(i) allows EPA to establish a tolerance (the legal limit
for a pesticide chemical residue in or on a food) only if EPA
determines that the tolerance is ``safe.'' FFDCA section
408(b)(2)(A)(ii) defines ``safe'' to mean that ``there is a reasonable
certainty that no harm will result from aggregate exposure to the
pesticide chemical residue, including all anticipated dietary exposures
and all other exposures for which there is reliable information.'' This
includes exposure through drinking water and in residential settings
but does not include occupational exposure. FFDCA section 408(b)(2)(C)
requires EPA to give special consideration to exposure of infants and
children to the pesticide chemical residue in establishing a tolerance
and
[[Page 8120]]
to ``ensure that there is a reasonable certainty that no harm will
result to infants and children from aggregate exposure to the pesticide
chemical residue . . .''
C. How can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a(g), any person may file
an objection to any aspect of this regulation and may also request a
hearing on those objections. If you fail to file an objection to the
final rule within the time period specified in the final rule, you will
have waived the right to raise any issues resolved in the final rule.
You must file your objection or request a hearing on this regulation in
accordance with the instructions provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must identify docket ID number EPA-HQ-OPP-
2021-0433 or EPA-HQ-OPP-2021-0833 in the subject line on the first page
of your submission. This document addresses two related petitions for
inpyrfluxam tolerance that were received by the Agency at different
times and are docketed under EPA-HQ-OPP-2021-0433 and EPA-HQ-OPP-2021-
0833. This final rule and all supporting documents will be uploaded to
both dockets, EPA-HQ-OPP-2021-0433 and EPA-HQ-OPP-2021-0833. All
objections and requests for a hearing must be in writing and must be
received by the Hearing Clerk on or before April 21, 2026.
The EPA's Office of Administrative Law Judges (OALJ), in which the
Hearing Clerk is housed, urges parties to file and serve documents by
electronic means only, notwithstanding any other particular
requirements set forth in other procedural rules governing those
proceedings. See ``Revised Order Urging Electronic Filing and
Service,'' dated June 22, 2023, which can be found at <a href="https://www.epa.gov/system/files/documents/2023-06/2023-06-22%20-%20revised%20order%20urging%20electronic%20filing%20and%20service.pdf">https://www.epa.gov/system/files/documents/2023-06/2023-06-22%20-%20revised%20order%20urging%20electronic%20filing%20and%20service.pdf</a>.
Although the EPA's regulations require submission via U.S. Mail or hand
delivery, the EPA intends to treat submissions filed via electronic
means as properly filed submissions; therefore, the EPA believes the
preference for submission via electronic means will not be prejudicial.
When submitting documents to the OALJ electronically, a person should
utilize the OALJ e-filing system at <a href="https://yosemite.epa.gov/oa/eab/eab-alj_upload.nsf">https://yosemite.epa.gov/oa/eab/eab-alj_upload.nsf</a>.
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket at <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Follow
the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute. If you wish to
include CBI in your request, please follow the applicable instructions
at <a href="https://www.epa.gov/dockets/commenting-epa-dockets#rules">https://www.epa.gov/dockets/commenting-epa-dockets#rules</a> and clearly
mark the information that you claim to be CBI. Information not marked
confidential pursuant to 40 CFR part 2 may be disclosed publicly by EPA
without prior notice.
II. Petitioned-For Tolerance
In the Federal Register of June 22, 2022 (87 FR 37287) (FRL-9410-
02-OCSPP), EPA issued a document pursuant to FFDCA section 408(d)(3),
21 U.S.C. 346a(d)(3), announcing the filing of pesticide petitions (PP
1F8922, PP 1F8924, and PP 1F8942) by Valent U.S.A. LLC, 4600 Norris
Canyon Road, San Ramon, CA 94583. The petitions requested that 40 CFR
part 180 be amended by establishing tolerances for residues of the
fungicide inpyrfluxam, (3-(difluoromethyl)-N-[(3R)-2,3-dihydro-1,1,3-
trimethyl-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide), in or on
cotton, undelinted seed, at 0.01 parts per million (ppm) (PP 1F8922);
cotton, gin byproducts (gin trash) at 0.02 ppm (PP 1F8922); wheat,
forage at 0.01 ppm (PP 1F8924); wheat, grain at 0.01 ppm (PP 1F8924);
wheat, hay at 1.5 ppm (PP 1F8924); wheat, straw at 0.3 ppm (PP 1F8924);
and rapeseed, seed (crop subgroup 20A) at 0.01 ppm (PP 1F8942). That
document referenced a summary of the three petitions prepared by Valent
U.S.A. LLC, the registrant, which is available in the docket <a href="http://www.regulations.gov">http://www.regulations.gov</a> (docket ID numbers EPA-HQ-OPP-2021-0433 and EPA-HQ-
OPP-2021-0833). There were no comments received in response to the June
22, 2022, notice of filing.
In the Federal Register of May 22, 2024 (89 FR 44954) (FRL-11682-
04-OCSPP), EPA issued a notice that supersedes the June 22, 2022,
notice of filing for PP 1F8942. This amended petition requests
tolerances for residues of inpyrfluxam in or on rapeseed subgroup 20A
at 0.01 ppm and ``rapeseed, forage'' at 0.02 ppm. One comment was
received in response to the May 22, 2024, notice but was not germane to
the petition.
EPA is not establishing a tolerance on ``rapeseed, forage'' as
requested in PP 1F8942. The reason for this change is explained in Unit
IV.D.
III. Final Tolerance Action
A. Aggregate Risk Assessment and Determination of Safety
Consistent with FFDCA section 408(b)(2)(D), and the factors
specified in FFDCA section 408(b)(2)(D), EPA has reviewed the available
scientific data and other relevant information in support of this
action. EPA has sufficient data to assess the hazards of and to make a
determination on aggregate exposure for inpyrfluxam, including exposure
resulting from the tolerances established by this action. EPA's
assessment of exposures and risks associated with inpyrfluxam follows.
In an effort to streamline its publications in the Federal
Register, EPA is not reprinting sections of the rule that repeat what
has been previously published in tolerance rulemakings for the same
pesticide chemical. Where scientific information concerning a
particular chemical remains unchanged, the content of those sections
would not vary between tolerance rulemakings, and EPA considers
referral back to those sections as sufficient to provide an explanation
of the information EPA considered in making its safety determination
for the new rulemaking.
EPA has previously published a tolerance rulemaking for inpyrfluxam
in which EPA concluded, based on the available information, that there
is a reasonable certainty that no harm would result from aggregate
exposure to inpyrfluxam and established tolerances for residues of that
chemical. EPA is incorporating previously published sections from that
rulemaking as described further in this rule, as they remain unchanged.
B. Toxicological Profile
EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children.
Specific information on the studies received and the nature of the
adverse effects caused by inpyrfluxam as well as the no-observed-
adverse-effect-level (NOAEL) and the lowest-observed-adverse-effect-
level (LOAEL) from the toxicity studies are discussed in the final rule
published in Unit III.A. of the Federal Register of August 26, 2020 (85
FR 52483) (FRL-10011-32).
[[Page 8121]]
C. Toxicological Points of Departure/Levels of Concern
Once a pesticide's toxicological profile is determined, EPA
identifies toxicological points of departure (POD) and levels of
concern to use in evaluating the risk posed by human exposure to the
pesticide. For hazards that have a threshold below which there is no
appreciable risk, the toxicological POD is used as the basis for
derivation of reference values for risk assessment. PODs are developed
based on a careful analysis of the doses in each toxicological study to
determine the dose at which no adverse effects are observed (the NOAEL)
and the lowest dose at which adverse effects of concern are identified
(the LOAEL). Uncertainty/safety factors are used in conjunction with
the POD to calculate a safe exposure level, generally referred to as a
population-adjusted dose (PAD) or a reference dose (RfD), and a safe
margin of exposure (MOE). For non-threshold risks, the Agency assumes
that any amount of exposure will lead to some degree of risk. Thus, the
Agency estimates risk in terms of the probability of an occurrence of
the adverse effect expected in a lifetime. For more information on the
general principles EPA uses in risk characterization and a complete
description of the risk assessment process, see <a href="https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/human-health-risk-pesticides">https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/human-health-risk-pesticides</a>.
A summary of the toxicological endpoints for inpyrfluxam used for
human risk assessment can be found at <a href="http://www.regulations.gov">http://www.regulations.gov</a> in the
document ``Inpyrfluxam. Human Health Risk Assessment for the Proposed
New Use of Inpyrfluxam as a Seed Treatment on Canola and Rate Increase
for Rapeseed Subgroup 20A.'' and ``Inpyrfluxam. Human Health Risk
Assessment for New Uses of Inpyrfluxam on Cottonseed and Wheat.''
(hereinafter ``Inpyrfluxam Human Health Risk Assessment'') on pages 16
and 18, respectively, in Docket ID numbers EPA-HQ-OPP-2021-0433 and
EPA-HQ-OPP-2021-0833.
D. Exposure Assessment
1. Dietary exposure from food and feed uses.
In evaluating dietary exposure to inpyrfluxam, EPA considered
exposure under the petitioned-for tolerances as well as all existing
inpyrfluxam tolerances in 40 CFR 180.712. EPA assessed dietary
exposures from inpyrfluxam in food as follows:
i. Acute exposure. Quantitative acute dietary exposure and risk
assessments are performed for a food-use pesticide, if a toxicological
study has indicated the possibility of an effect of concern occurring
as a result of a 1-day or single exposure.
The acute and chronic dietary assessment were conducted using the
Dietary Exposure Evaluation Model software with the Food Commodity
Intake Database (DEEM-FCID) Version 4.02. This software uses 2005-2010
food consumption data from the U.S. Department of Agriculture (USDA)
National Health and Nutrition Examination Survey, What We Eat in
America. As to residue levels in food, the acute and chronic analyses
incorporated anticipated residues to account for the metabolites of
concern, 100 percent crop treated (PCT) estimates, default processing
factors for processed commodities and empirical processing factors when
available.
ii. Cancer. Based on the data summarized in Unit III.A., EPA has
concluded that inpyrfluxam does not pose a cancer risk to humans.
Therefore, a dietary exposure assessment for the purpose of assessing
cancer risk is unnecessary.
2. Dietary exposure from drinking water.
The proposed uses do not result in an increase in the estimated
residue levels in drinking water, so the estimated drinking water
concentrations used in the August 26, 2020, final rule (85 FR 52483)
(FRL-10011-32) are the same as those used in this assessment.
3. From non-dietary exposure.
The term ``residential exposure'' is used in this document to refer
to non-occupational, non-dietary exposure (e.g., for lawn and garden
pest control, indoor pest control, termiticides, and flea and tick
control on pets). Inpyrfluxam is not registered for any specific use
patterns that would result in residential exposure.
4. Cumulative effects from substances with a common mechanism of
toxicity.
Section 408(b)(2)(D)(v) of FFDCA requires that, when considering
whether to establish, modify, or revoke a tolerance, the Agency
consider ``available information'' concerning the cumulative effects of
a particular pesticide's residues and ``other substances that have a
common mechanism of toxicity.''
EPA has not found inpyrfluxam to share a common mechanism of
toxicity with any other substances, and inpyrfluxam does not appear to
produce a toxic metabolite produced by other substances. For the
purposes of this tolerance action, therefore, EPA has assumed that
inpyrfluxam does not have a common mechanism of toxicity with other
substances. For information regarding EPA's efforts to determine which
chemicals have a common mechanism of toxicity and to evaluate the
cumulative effects of such chemicals, see EPA's website at <a href="https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/cumulative-assessment-risk-pesticides">https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/cumulative-assessment-risk-pesticides</a>.
E. Safety Factor for Infants and Children
EPA continues to conclude that there are reliable data to support
the reduction of the Food Quality Protection Act (FQPA) safety factor.
See Unit III.D. of the August 26, 2020, rulemaking (85 FR 52483) (FRL-
10011-32) for a discussion of the Agency's rationale for that
determination.
F. Aggregate Risks and Determination of Safety
EPA determines whether acute and chronic dietary pesticide
exposures are safe by comparing dietary exposure estimates to the acute
PAD (aPAD) and chronic PAD (cPAD). Short-, intermediate-, and chronic-
term aggregate risks are evaluated by comparing the estimated total
food, water, and residential exposure to the appropriate PODs to ensure
that an adequate MOE exists.
1. Acute risk. An acute aggregate risk assessment takes into
account acute exposure estimates from dietary consumption of food and
drinking water. Using the exposure assumptions discussed in this unit
for acute exposure, the acute dietary exposure from food and water to
inpyrfluxam will occupy 6.8% of the aPAD for all infants less than one
year old, the population group receiving the greatest exposure.
2. Chronic risk. Using the exposure assumptions described in this
unit for chronic exposure, EPA has concluded that chronic exposure to
inpyrfluxam from food and water will utilize 2.4% of the cPAD for all
infants less than one year old, the population group receiving the
greatest exposure. There are no residential uses for inpyrfluxam.
3. Short- and intermediate-term risk. Short-term aggregate exposure
takes into account short-term residential exposure plus chronic
exposure to food and water (considered to be a background exposure
level). Short-term risk is assessed based on short-term residential
exposure plus chronic dietary exposure. Because there is no short-term
or intermediate residential exposure and chronic dietary exposure has
already been assessed under the appropriately protective cPAD (which is
at least as protective as the POD used to assess short-term risk), no
further assessment of short-term or intermediate-term risk
[[Page 8122]]
is necessary, and EPA relies on the chronic dietary risk assessment for
evaluating the aggregate risk for inpyrfluxam.
4. Aggregate cancer risk for U.S. population. Based on the lack of
evidence of carcinogenicity in two adequate rodent carcinogenicity
studies, inpyrfluxam is not expected to pose a cancer risk to humans.
5. Determination of safety. Based on these risk assessments, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population, or to infants and children from aggregate
exposure to inpyrfluxam residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
For a discussion of the available enforcement analytical methods,
see Unit IV.A. of the August 26, 2020, rulemaking (85 FR 52483) (FRL-
10011-32).
B. International Residue Limits
In making its tolerance decisions, EPA seeks to harmonize U.S.
tolerances with international standards whenever possible, consistent
with U.S. food safety standards and agricultural practices. EPA
considers the international maximum residue limits (MRL) established by
the Codex Alimentarius Commission (Codex), as required by FFDCA section
408(b)(4). The Codex is a joint United Nations Food and Agriculture
Organization/World Health Organization food standards program, and it
is recognized as an international food safety standards-setting
organization in trade agreements to which the United States is a party.
EPA may establish a tolerance that is different from a Codex MRL;
however, FFDCA section 408(b)(4) requires that EPA explain the reasons
for departing from the Codex level.
Codex has not established MRLs for inpyrfluxam in/on cottonseed,
rapeseed, or wheat.
C. Revisions to Petitioned-For Tolerances
Although the petition requested a tolerance for ``rapeseed,
forage'', EPA has determined that the ``rapeseed, forage'' tolerance is
not needed because the proposed pesticide product label prohibits
livestock feeding and grazing of rapeseed forage (canola varieties
only) treated with inpyrfluxam. The commodity definition for cotton,
gin byproducts (gin trash) was also revised in conformity with EPA
guidelines.
V. Conclusion
Therefore, tolerances are established for residues of inpyrfluxam,
(3-(difluoromethyl)-N-[(3R)-2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl]-
1-methyl-1H-pyrazole-4-carboxamide), in or on cotton, gin byproducts at
0.02 ppm; cotton, undelinted seed at 0.01 ppm; rapeseed subgroup 20A at
0.01 ppm; wheat, forage at 0.01 ppm; wheat, grain at 0.01 ppm; wheat,
hay at 1.5 ppm; and wheat, straw at 0.3 ppm.
VI. Statutory and Executive Order Reviews
Additional information about these statutes and Executive orders
can be found at <a href="https://www.epa.gov/regulations/and-executive-orders">https://www.epa.gov/regulations/and-executive-orders</a>.
A. Executive Order 12866: Regulatory Planning and Review
This action is exempt from review under Executive Order 12866 (58
FR 51735, October 4, 1993), because it establishes or modifies a
pesticide tolerance or a tolerance exemption under FFDCA section 408 in
response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866.
B. Executive Order 14192: Unleashing Prosperity Through Deregulation
Executive Order 14192 (90 FR 9065, February 6, 2025) does not apply
because actions that establish a tolerance under FFDCA section 408 are
exempted from review under Executive Order 12866.
C. Paperwork Reduction Act (PRA)
This action does not impose an information collection burden under
the PRA 44 U.S.C. 3501 et seq., because it does not contain any
information collection activities.
D. Regulatory Flexibility Act (RFA)
Since tolerance actions that are established on the basis of a
petition under FFDCA section 408(d), such as the tolerance in this
final rule, do not require the issuance of a proposed rule, the
requirements of the RFA, 5 U.S.C. 601 et seq., do not apply to this
action.
E. Unfunded Mandates Reform Act (UMRA)
This action does not contain an unfunded mandate of $100 million or
more (in 1995 dollars and adjusted annually for inflation) as described
in UMRA, 2 U.S.C. 1531-1538, and does not significantly or uniquely
affect small governments. The action imposes no enforceable duty on any
State, local, or Tribal governments or on the private sector.
F. Executive Order 13132: Federalism
This action does not have federalism implications as specified in
Executive Order 13132 (64 FR 43255, August 10, 1999), because it will
not have substantial direct effects on the States, on the relationship
between the National Government and the States, or on the distribution
of power and responsibilities among the various levels of government.
G. Executive Order 13175: Consultation and Coordination With Indian
Tribal Governments
This action does not have Tribal implications as specified in
Executive Order 13175 (65 FR 67249, November 9, 2000), because it will
not have substantial direct effects on Tribal governments, on the
relationship between the Federal Government and the Indian Tribes, or
on the distribution of power and responsibilities between the Federal
Government and Indian Tribes.
H. Executive Order 13045: Protection of Children From Environmental
Health Risks and Safety Risks
This action is not subject to Executive Order 13045 (62 FR 19885,
April 23, 1997) because tolerance actions like this one are exempt from
review under Executive Order 12866. However, EPA's 2021 Policy on
Children's Health applies to this action. This rule finalizes tolerance
actions under the FFDCA, which requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue . .
.'' (FFDCA 408(b)(2)(C)). The Agency's consideration is summarized in
Unit III.E.
I. Executive Order 13211: Actions Concerning Regulations That
Significantly Affect Energy Supply, Distribution or Use
This action is not subject to Executive Order 13211 (66 FR 28355)
(May 22, 2001) because it is not a significant regulatory action under
Executive Order 12866.
J. National Technology Transfer Advancement Act (NTTAA)
This action does not involve technical standards that would require
Agency consideration under NTTAA section 12(d), 15 U.S.C. 272.
[[Page 8123]]
K. Congressional Review Act (CRA)
This action is subject to the CRA, 5 U.S.C. 801 et seq., and EPA
will submit a rule report to each House of the Congress and to the
Comptroller General of the United States. This action is not a ``major
rule'' as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: February 11, 2026.
Charles Smith,
Director, Registration Division, Office of Pesticide Programs.
For the reasons set forth in the preamble, 40 CFR chapter I is
amended as follows:
PART 180--TOLERANCES AND EXEMPTIONS FOR PESTICIDE CHEMICAL RESIDUES
IN FOOD
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. Amend Sec. 180.712 paragraph (a)(1) in Table 1 to Sec. 180.712 by
adding the entries for ``Cotton, gin byproducts'', ``Cotton, undelinted
seed'', ``Rapeseed subgroup 20A'', ``Wheat, forage'', ``Wheat, grain'',
Wheat, hay'', and ``Wheat, straw'', in alphabetical order, to read as
follows:
Sec. 180.712 Inpyrfluxam; tolerances for residues.
(a) * * *
(1) * * *
Table 1 to Sec. 180.712
------------------------------------------------------------------------
Commodity Parts per million
------------------------------------------------------------------------
* * * * *
Cotton, gin byproducts............................... 0.02
Cotton, undelinted seed.............................. 0.01
* * * * *
Rapeseed subgroup 20A................................ 0.01
* * * * *
Wheat, forage........................................ 0.01
Wheat, grain......................................... 0.01
Wheat, hay........................................... 1.5
Wheat, straw......................................... 0.3
------------------------------------------------------------------------
* * * * *
[FR Doc. 2026-03423 Filed 2-19-26; 8:45 am]
BILLING CODE 6560-50-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 20, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.